Cannabis Therapy for Epilepsy – Dr Evan Lewis 16th September
Raphael Mechoulam – 9th September
Dr Raphael Mechoulam: the chemist responsible for isolating Tetrahydrocannabinol addressed attendees in the keynote speech at the International Cannabis Business Conference in Berlin to explain his cannabis research which unleashed the secrets of the cannabis plant.
Best known for his discovery of tetrahydrocannabinol (THC), one of the 113 known cannabinoids found in the cannabis plant. Mechoulam jumpstarted the medical revolution which has transformed the debate around cannabis and the lives of so many people.
The future of Medical Cannabis in UK – Dr Benjamin Viaris de Lesegno
Co-founder and CMO of Cellen. Cellen is a HealthTech company on a mission to improve the health and wellbeing of people living with chronic conditions.
I have been an NHS consultant since 2016. I trained in France where I have been Chef de Clinique – Assistant universitaire des hôpitaux de Paris. I practice Obstetrics and Gynaecology and trained in Maternal and Fetal Medicine. I also have an MSc in Genetics. I participate in research and teaching in my daily life.
I have been on several humanitarians missions and have worked in places as different as the slums of India, Syrian refugee camps at the beginning of the war, the Jungle of Calais with migrant population from Africa, the Middle East or South east Asia.
When I am not delivering babies, doing researching on fetal genetic diseases, teaching to medical students or caring for patients in a refugee camp, I actively participate in the Health Tech scenes in France and in the UK. I am the founder and organiser of the first Startup Weekend Health in France and in the UK. I am the Techstars mentor in Health Tech for the London accelerator, belong to the CCIO network, am the Health Tech Chapter Leader for the French Tech, etc.
Benjamin had an open and frank discussion with parents of Medcan about the future of medical cannabis in the UK and access on the NHS.